Minister for Exports Congratulates ApconiX

Minister for Exports, Mike Freer congratulated ApconiX for being honoured with the Queen's Award for Enterprise.  The three Directors and Co-founders, Dr Richard Knight, Dr Michael Morton and Professor Ruth Roberts are all delighted that their hard work and determination and that of the whole team at ApconiX has been recognised for the [...]

By |2022-06-08T14:11:42+01:00June 6th, 2022|Company News|Comments Off on Minister for Exports Congratulates ApconiX

Unravelling Some Mechanistic and Clinical Aspects of Immunological Drug-Drug Interactions

Unravelling Some Mechanistic and Clinical Aspects of Immunological Drug-Drug Interactions Dr Sean Hammond, as a member of an interdisciplinary team, has recently published the third of a series of papers seeking to unravel mechanistic and clinical aspects of the immunological drug-drug interactions that occur with immune checkpoint inhibitors. Immunotoxicology [...]

By |2022-06-08T13:14:11+01:00June 6th, 2022|Company News, Target Safety Assessments, Careers|Comments Off on Unravelling Some Mechanistic and Clinical Aspects of Immunological Drug-Drug Interactions

The Importance of “Agility” Post COVID

The Importance of "Agility" Post COVID In 2021, we shared our whole-hearted agreement with the 2020 Forbes Article describing agility as the new superpower.  Agility certainly allowed ApconiX to thrive and grow during the pandemic by focusing on the science and on people rather than on any pre-existing plans or process, allowing our [...]

By |2022-06-01T16:45:47+01:00June 1st, 2022|Company News|Comments Off on The Importance of “Agility” Post COVID

ApconiX Is Recruiting a Target Safety Biologist

ApconiX Is Recruiting a Target Safety Biologist ApconiX is a team of world-renowned nonclinical safety experts with over 400 years of drug discovery and development expertise. We were formed in 2015 by three scientists with the drive and ambition to create a world-renowned company. We are now looking to grow [...]

By |2022-05-31T14:39:45+01:00May 31st, 2022|Company News, Target Safety Assessments, Careers|Comments Off on ApconiX Is Recruiting a Target Safety Biologist

New Paper Published in Birth Defects Research

New Paper Published in Birth Defects Research Dr Jane Barber, Dr Claire Sadler and Dr Jane Stewart are among the authors of new paper published in Birth Defects Research. The Paper Malarial PI4K inhibitor induced diaphragmatic hernias in rat: Potential link with mammalian kinase inhibition Abstract Background MMV390048 is [...]

By |2022-05-10T13:57:30+01:00May 6th, 2022|Company News, Toxicology, Publications|Comments Off on New Paper Published in Birth Defects Research

ApconiX Wins the Queen’s Award for Enterprise

ApconiX Wins the Queen’s Award for Enterprise ApconiX is delighted to be honoured with a Queen’s Award for Enterprise.  Announced today (21st April) ApconiX has been recognised for its excellence in International Trade. ApconiX was founded by Dr Richard Knight, Professor Ruth Roberts and Dr Michael Morton, ex-AstraZeneca colleagues [...]

By |2022-04-21T11:10:37+01:00April 21st, 2022|Company News|Comments Off on ApconiX Wins the Queen’s Award for Enterprise

Professor Ruth Roberts Receives the SOT Drug Discovery Toxicology Specialty Section Paper of the Year Award for 2021

Professor Ruth Roberts Receives the SOT Drug Discovery Toxicology Specialty Section Paper of the Year Award for 2021 The Drug Discovery Toxicology Specialty Section of SOT has selected Professor Ruth Roberts as the recipient of their Paper of the Year Award for 2021. The Paper of the Year Award [...]

By |2022-03-31T14:04:46+01:00March 31st, 2022|Company News, Toxicology|Comments Off on Professor Ruth Roberts Receives the SOT Drug Discovery Toxicology Specialty Section Paper of the Year Award for 2021

ApconiX Will Be Attending the British Society of Toxicology Congress 2022

ApconiX Attends British Society of Toxicology Congress 2022 Professor Ruth Roberts, Dr Laurence Bishop, Dr Kimberly Rockley, Dr Sean Hammond and Nicholas Coltman will be attending the British Society of Toxicology Congress 2022 from the 4th to 6th of April at the Hilton Newcastle in Gateshead UK. ApconiX will [...]

By |2022-03-23T11:58:12+00:00March 22nd, 2022|Company News, Toxicology, Events|Comments Off on ApconiX Will Be Attending the British Society of Toxicology Congress 2022

We’re Attending SOT 2022

ApconiX is Attending the 61st Society of Toxicology Annual Meeting and ToxExpo Professor Ruth Roberts, Dr Richard Knight, Dr Michael Morton, Dr Laurence Bishop, Dr James Sidaway, Dr Claire Sadler, Dr Kimberly Rockley, Simon Craige, and Dr Andrew Winkley will all be attending the SOT 2022 Annual Meeting and [...]

By |2022-03-11T14:46:05+00:00March 11th, 2022|Company News, Events|Comments Off on We’re Attending SOT 2022

Professor Ruth Roberts Is the Mildred S. Christian Career Achievement 2022 Award Recipient

Professor Ruth Roberts Is the Mildred S. Christian Career Achievement 2022 Award Recipient Professor Ruth Roberts received the Academy of Toxicological Sciences’ Mildred S. Christian Career Achievement award for 2022. The Mildred S. Christian Career Achievement Award The Mildred S. Christian Career Achievement Award was established to honour the [...]

By |2022-03-09T16:31:57+00:00March 9th, 2022|Company News, Toxicology|Comments Off on Professor Ruth Roberts Is the Mildred S. Christian Career Achievement 2022 Award Recipient
Go to Top